cancer vaccine News
Most Popular cancer vaccine Story
Peptide could be clue for cancer vax
In a recent study, 100 percent of mice vaccinated with a peptide remained tumor-free for at least 60 days after inoculation with colon cancer cells. And scientists from the University of Colorado... Read more...
Latest Headlines
- February 17, 2010
- January 6, 2010
- November 5, 2009
- June 25, 2009
- June 3, 2009
- April 16, 2009
- March 25, 2009
- December 18, 2008
- November 20, 2008
- October 16, 2008
- September 18, 2008
- September 18, 2008
- September 4, 2008
- August 28, 2008
- April 10, 2008
- April 3, 2008
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
